Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$57.6 - $70.59 $127,180 - $155,862
-2,208 Closed
0 $0
Q2 2021

Jul 30, 2021

SELL
$51.81 - $118.56 $68,492 - $156,736
-1,322 Reduced 37.45%
2,208 $147,000
Q1 2021

May 07, 2021

SELL
$111.01 - $139.48 $5,328 - $6,695
-48 Reduced 1.34%
3,530 $392,000
Q4 2020

Feb 12, 2021

SELL
$88.75 - $119.95 $275,480 - $372,324
-3,104 Reduced 46.45%
3,578 $425,000
Q3 2020

Nov 16, 2020

SELL
$75.65 - $93.58 $370,382 - $458,167
-4,896 Reduced 42.29%
6,682 $583,000
Q2 2020

Aug 12, 2020

SELL
$84.96 - $118.91 $242,135 - $338,893
-2,850 Reduced 19.75%
11,578 $1.04 Million
Q1 2020

May 15, 2020

SELL
$74.34 - $121.82 $60,884 - $99,770
-819 Reduced 5.37%
14,428 $1.44 Million
Q4 2019

Feb 14, 2020

BUY
$114.37 - $129.46 $27,448 - $31,070
240 Added 1.6%
15,247 $1.75 Million
Q3 2019

Nov 14, 2019

BUY
$117.16 - $138.52 $236,311 - $279,394
2,017 Added 15.53%
15,007 $1.89 Million
Q2 2019

Aug 14, 2019

BUY
$81.74 - $120.34 $37,518 - $55,236
459 Added 3.66%
12,990 $1.56 Million
Q1 2019

May 15, 2019

BUY
$83.25 - $102.12 $163,170 - $200,155
1,960 Added 18.54%
12,531 $1.1 Million
Q4 2018

Jan 31, 2019

BUY
$90.66 - $116.63 $384,851 - $495,094
4,245 Added 67.1%
10,571 $1.06 Million
Q3 2018

Nov 15, 2018

BUY
$89.96 - $114.58 $472,200 - $601,430
5,249 Added 487.37%
6,326 $725,000
Q2 2018

Aug 22, 2018

SELL
$71.53 - $95.75 $2.81 Million - $3.76 Million
-39,302 Reduced 97.33%
1,077 $96,000
Q2 2018

Aug 15, 2018

BUY
$71.53 - $95.75 $2.89 Million - $3.87 Million
40,379 New
40,379 $95,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.36B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.